Brain endothelial TAK1 and NEMO safeguard the neurovascular unit.
Brain endothelial TAK1 and NEMO safeguard the neurovascular unit.
复制标题
DOI:
10.1084/jem.20150165
复制
发表时间:
2015-09-21
期刊:
影响因子:
--
通讯作者:
Schwaninger M
中科院分区:
文献类型:
--
作者:
Ridder DA;Wenzel J;Müller K;Töllner K;Tong XK;Assmann JC;Stroobants S;Weber T;Niturad C;Fischer L;Lembrich B;Wolburg H;Grand'Maison M;Papadopoulos P;Korpos E;Truchetet F;Rades D;Sorokin LM;Schmidt-Supprian M;Bedell BJ;Pasparakis M;Balschun D;D'Hooge R;Löscher W;Hamel E;Schwaninger M
Ridder et al. show that deletion of NEMO, a component of NF-kB signaling, in brain endothelial cells results in increased cerebral vascular permeability and endothelial cell death, and recapitulates the neurological symptoms observed in the genetic disease incontinentia pigmenti. Inactivating mutations of the NF-κB essential modulator (NEMO), a key component of NF-κB signaling, cause the genetic disease incontinentia pigmenti (IP). This leads to severe neurological symptoms, but the mechanisms underlying brain involvement were unclear. Here, we show that selectively deleting Nemo or the upstream kinase Tak1 in brain endothelial cells resulted in death of endothelial cells, a rarefaction of brain microvessels, cerebral hypoperfusion, a disrupted blood–brain barrier (BBB), and epileptic seizures. TAK1 and NEMO protected the BBB by activating the transcription factor NF-κB and stabilizing the tight junction protein occludin. They also prevented brain endothelial cell death in a NF-κB–independent manner by reducing oxidative damage. Our data identify crucial functions of inflammatory TAK1–NEMO signaling in protecting the brain endothelium and maintaining normal brain function, thus explaining the neurological symptoms associated with IP.